| Natera
1 1
2 2
3 3
4 4
5 5

The choice to use cord blood stem cells will depend on a variety of factors – only a physician can determine when cord blood stem cells should be used, on a case by case basis. Many of the conditions currently treated with cord blood stem cells are genetic diseases. There is no guarantee that your physician will choose stem cell transplant over other courses of treatment. Unlike cord blood, there are currently no proven treatments using cord tissue stem cells.

Activities for New York State residents are limited to collection of umbilical cord tissue and processing and long-term storage of umbilical cord tissue or cord tissue-derived cells. The tissue bank's possession of a New York State license for such collection, processing and/or long-term storage does not indicate approval or endorsement of possible future uses or future suitability of these cells.

Natera and Bloodworks are in a partnership to create Evercord™, an offering that enables expectant parents to collect, store and potentially retrieve their newborn’s cord blood and tissue for therapeutic use in transplantation and regenerative medicine applications. The transplant data cited is from Bloodworks’ prior experience as a public cord blood bank. This data is referenced as proof of the quality processing and preservation systems for the Evercord product that are designed to enable transplantation when needed, and as a reference point for families who purchase the Evercord product.